Cargando…

Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension

OBJECTIVE—: Serotonin can induce human pulmonary artery smooth muscle cell (hPASMC) proliferation through reactive oxygen species (ROS), influencing the development of pulmonary arterial hypertension (PAH). We hypothesize that in PASMCs, serotonin induces oxidative stress through NADPH-oxidase–deriv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hood, Katie Y., Mair, Kirsty M., Harvey, Adam P., Montezano, Augusto C., Touyz, Rhian M., MacLean, Margaret R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478178/
https://www.ncbi.nlm.nih.gov/pubmed/28473438
http://dx.doi.org/10.1161/ATVBAHA.116.308929
_version_ 1783244910064828416
author Hood, Katie Y.
Mair, Kirsty M.
Harvey, Adam P.
Montezano, Augusto C.
Touyz, Rhian M.
MacLean, Margaret R.
author_facet Hood, Katie Y.
Mair, Kirsty M.
Harvey, Adam P.
Montezano, Augusto C.
Touyz, Rhian M.
MacLean, Margaret R.
author_sort Hood, Katie Y.
collection PubMed
description OBJECTIVE—: Serotonin can induce human pulmonary artery smooth muscle cell (hPASMC) proliferation through reactive oxygen species (ROS), influencing the development of pulmonary arterial hypertension (PAH). We hypothesize that in PASMCs, serotonin induces oxidative stress through NADPH-oxidase–derived ROS generation and reduced Nrf-2 (nuclear factor [erythroid-derived 2]-like 2) antioxidant systems, promoting vascular injury. APPROACH AND RESULTS—: HPASMCs from controls and PAH patients, and PASMCs from Nox1(−/−) mice, were stimulated with serotonin in the absence/presence of inhibitors of Src kinase, the 5-HT(1B) receptor, and NADPH oxidase 1 (Nox1). Markers of fibrosis were also determined. The pathophysiological significance of our findings was examined in vivo in serotonin transporter overexpressing female mice, a model of pulmonary hypertension. We confirmed thatserotonin increased superoxide and hydrogen peroxide production in these cells. For the first time, we show that serotonin increased oxidized protein tyrosine phosphatases and hyperoxidized peroxiredoxin and decreased Nrf-2 and catalase activity in hPASMCs. ROS generation was exaggerated and dependent on cellular Src-related kinase, 5-HT(1B) receptor, and the serotonin transporter in human pulmonary artery smooth muscle cells from PAH subjects. Proliferation and extracellular matrix remodeling were exaggerated in human pulmonary artery smooth muscle cells from PAH subjects and dependent on 5-HT(1B) receptor signaling and Nox1, confirmed in PASMCs from Nox1(−/−) mice. In serotonin transporter overexpressing mice, SB216641, a 5-HT(1B) receptor antagonist, prevented development of pulmonary hypertension in a ROS-dependent manner. CONCLUSIONS—: Serotonin can induce cellular Src-related kinase–regulated Nox1-induced ROS and Nrf-2 dysregulation, contributing to increased post-translational oxidative modification of proteins and activation of redox-sensitive signaling pathways in hPASMCs, associated with mitogenic responses. 5-HT(1B) receptors contribute to experimental pulmonary hypertension by inducing lung ROS production. Our results suggest that 5-HT(1B) receptor–dependent cellular Src-related kinase-Nox1-pathways contribute to vascular remodeling in PAH.
format Online
Article
Text
id pubmed-5478178
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-54781782017-06-30 Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension Hood, Katie Y. Mair, Kirsty M. Harvey, Adam P. Montezano, Augusto C. Touyz, Rhian M. MacLean, Margaret R. Arterioscler Thromb Vasc Biol Basic Sciences OBJECTIVE—: Serotonin can induce human pulmonary artery smooth muscle cell (hPASMC) proliferation through reactive oxygen species (ROS), influencing the development of pulmonary arterial hypertension (PAH). We hypothesize that in PASMCs, serotonin induces oxidative stress through NADPH-oxidase–derived ROS generation and reduced Nrf-2 (nuclear factor [erythroid-derived 2]-like 2) antioxidant systems, promoting vascular injury. APPROACH AND RESULTS—: HPASMCs from controls and PAH patients, and PASMCs from Nox1(−/−) mice, were stimulated with serotonin in the absence/presence of inhibitors of Src kinase, the 5-HT(1B) receptor, and NADPH oxidase 1 (Nox1). Markers of fibrosis were also determined. The pathophysiological significance of our findings was examined in vivo in serotonin transporter overexpressing female mice, a model of pulmonary hypertension. We confirmed thatserotonin increased superoxide and hydrogen peroxide production in these cells. For the first time, we show that serotonin increased oxidized protein tyrosine phosphatases and hyperoxidized peroxiredoxin and decreased Nrf-2 and catalase activity in hPASMCs. ROS generation was exaggerated and dependent on cellular Src-related kinase, 5-HT(1B) receptor, and the serotonin transporter in human pulmonary artery smooth muscle cells from PAH subjects. Proliferation and extracellular matrix remodeling were exaggerated in human pulmonary artery smooth muscle cells from PAH subjects and dependent on 5-HT(1B) receptor signaling and Nox1, confirmed in PASMCs from Nox1(−/−) mice. In serotonin transporter overexpressing mice, SB216641, a 5-HT(1B) receptor antagonist, prevented development of pulmonary hypertension in a ROS-dependent manner. CONCLUSIONS—: Serotonin can induce cellular Src-related kinase–regulated Nox1-induced ROS and Nrf-2 dysregulation, contributing to increased post-translational oxidative modification of proteins and activation of redox-sensitive signaling pathways in hPASMCs, associated with mitogenic responses. 5-HT(1B) receptors contribute to experimental pulmonary hypertension by inducing lung ROS production. Our results suggest that 5-HT(1B) receptor–dependent cellular Src-related kinase-Nox1-pathways contribute to vascular remodeling in PAH. Lippincott Williams & Wilkins 2017-07 2017-06-21 /pmc/articles/PMC5478178/ /pubmed/28473438 http://dx.doi.org/10.1161/ATVBAHA.116.308929 Text en © 2017 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Basic Sciences
Hood, Katie Y.
Mair, Kirsty M.
Harvey, Adam P.
Montezano, Augusto C.
Touyz, Rhian M.
MacLean, Margaret R.
Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
title Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
title_full Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
title_fullStr Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
title_full_unstemmed Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
title_short Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
title_sort serotonin signaling through the 5-ht(1b) receptor and nadph oxidase 1 in pulmonary arterial hypertension
topic Basic Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478178/
https://www.ncbi.nlm.nih.gov/pubmed/28473438
http://dx.doi.org/10.1161/ATVBAHA.116.308929
work_keys_str_mv AT hoodkatiey serotoninsignalingthroughthe5ht1breceptorandnadphoxidase1inpulmonaryarterialhypertension
AT mairkirstym serotoninsignalingthroughthe5ht1breceptorandnadphoxidase1inpulmonaryarterialhypertension
AT harveyadamp serotoninsignalingthroughthe5ht1breceptorandnadphoxidase1inpulmonaryarterialhypertension
AT montezanoaugustoc serotoninsignalingthroughthe5ht1breceptorandnadphoxidase1inpulmonaryarterialhypertension
AT touyzrhianm serotoninsignalingthroughthe5ht1breceptorandnadphoxidase1inpulmonaryarterialhypertension
AT macleanmargaretr serotoninsignalingthroughthe5ht1breceptorandnadphoxidase1inpulmonaryarterialhypertension